Continuous Intravenous Administration of Live Genetically Modified Salmonella Typhimurium in Patients With Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/00002371-200303000-00011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Dissemination and Proliferation of Salmonella Typhimurium in Genetically Resistant and Susceptible Mice

Journal of Medical Microbiology
MedicineMicrobiology
1992English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Antitumour Activity of Salmonella Typhimurium VNP20047 in B16(F10) Murine Melanoma Model.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2004English

Intravenous Administration of Diazepam in Patients With Chronic Liver Disease.

Gut
Gastroenterology
1976English

Improved Tolerability of a Salmonella Typhimurium Live-Attenuated Vaccine Strain by Balancing Inflammatory Potential With Immunogenicity

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2018English

Plasma Markers for Identifying Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Investigation Into the Capability of a Salmonella Choleraesuis Live Vaccine to Reduce the Shedding of Salmonella Typhimurium in Swine

1999English

Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells

Clinical Cancer Research
Cancer ResearchOncology
2009English

Foodborne Infection of Mice With Salmonella Typhimurium

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy